Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Goldman Sachs Downgrades Arvinas to Sell, Lowers Price Target to $6

Author: Benzinga Newsdesk | October 15, 2025 06:24am
Goldman Sachs analyst Paul Choi downgrades Arvinas (NASDAQ:ARVN) from Neutral to Sell and lowers the price target from $8 to $6.

Posted In: ARVN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist